CEVEC is a global solution provider focussing on the development of top notch human expression systems with highest ethical standards. Our platform expression technologies CAP and CAP-T are based on specific, amniocyte derived human cell lines.
CAP and CAP-T are designed for stable and transient protein production and achieve highest protein yields with authentic human glycosylation patterns.
We have a high focus on research and development, production and marketing of our cell systems for protein and vaccine production accompanied by our development of selected “bio-better” and “bio-superior” candidates.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 07/01/11 | Series B | 8.6M | Unknown |